Paul E. MacCosbe

522 total citations
8 papers, 353 citations indexed

About

Paul E. MacCosbe is a scholar working on Cardiology and Cardiovascular Medicine, Anesthesiology and Pain Medicine and Surgery. According to data from OpenAlex, Paul E. MacCosbe has authored 8 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 3 papers in Anesthesiology and Pain Medicine and 2 papers in Surgery. Recurrent topics in Paul E. MacCosbe's work include Anesthesia and Sedative Agents (3 papers), Bone health and treatments (2 papers) and Hemodynamic Monitoring and Therapy (2 papers). Paul E. MacCosbe is often cited by papers focused on Anesthesia and Sedative Agents (3 papers), Bone health and treatments (2 papers) and Hemodynamic Monitoring and Therapy (2 papers). Paul E. MacCosbe collaborates with scholars based in United States. Paul E. MacCosbe's co-authors include Robert R. Recker, Mark P. Ettinger, Atul Laddu, Prasad Turlapaty, James M. Kirshenbaum, Ruey J. Sung, William E. Pierson, Julie Hoff, Craig LaForce and Tsushung A. Hua and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Mayo Clinic Proceedings and American Journal of Hypertension.

In The Last Decade

Paul E. MacCosbe

7 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. MacCosbe United States 7 193 169 61 61 55 8 353
Robert J. Stine United States 8 227 1.2× 62 0.4× 136 2.2× 23 0.4× 4 0.1× 13 413
S Rabar United Kingdom 6 28 0.1× 15 0.1× 195 3.2× 95 1.6× 13 0.2× 7 383
Xavier Warling Belgium 8 34 0.2× 23 0.1× 42 0.7× 109 1.8× 5 0.1× 17 421
Kirk Midkiff United States 7 189 1.0× 195 1.2× 91 1.5× 40 0.7× 10 462
Chiara Veronesi Italy 10 27 0.1× 13 0.1× 105 1.7× 102 1.7× 21 0.4× 52 335
Jirat Chenbhanich United States 10 50 0.3× 59 0.3× 16 0.3× 51 0.8× 20 257
Amir Sharifuddin Md Khir Malaysia 12 34 0.2× 62 0.4× 68 1.1× 34 0.6× 1 0.0× 19 508
Adrián Guinsburg Germany 10 24 0.1× 37 0.2× 76 1.2× 34 0.6× 2 0.0× 23 495
Joseph Chiodo United States 10 51 0.3× 61 0.4× 104 1.7× 40 0.7× 17 477
Yin‐Fan Chang Taiwan 9 83 0.4× 29 0.2× 87 1.4× 18 0.3× 30 271

Countries citing papers authored by Paul E. MacCosbe

Since Specialization
Citations

This map shows the geographic impact of Paul E. MacCosbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. MacCosbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. MacCosbe more than expected).

Fields of papers citing papers by Paul E. MacCosbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. MacCosbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. MacCosbe. The network helps show where Paul E. MacCosbe may publish in the future.

Co-authorship network of co-authors of Paul E. MacCosbe

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. MacCosbe. A scholar is included among the top collaborators of Paul E. MacCosbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. MacCosbe. Paul E. MacCosbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ettinger, Mark P., et al.. (2006). Medication Persistence With Weekly Versus Daily Doses of Orally Administered Bisphosphonates. Endocrine Practice. 12(5). 522–528. 50 indexed citations
2.
Recker, Robert R., et al.. (2005). Effect of Dosing Frequency on Bisphosphonate Medication Adherence in a Large Longitudinal Cohort of Women. Mayo Clinic Proceedings. 80(7). 856–861. 209 indexed citations
3.
Dubois, Michel Y., et al.. (1992). Cerebral Blood Flow Measurements During Blood Pressure Control with Intravenous Labetalol Following Craniotomy. Journal of Neurosurgical Anesthesiology. 4(3). 176–181. 9 indexed citations
4.
Pierson, William E., et al.. (1990). Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. Journal of Allergy and Clinical Immunology. 85(3). 618–626. 18 indexed citations
5.
Thomas, Jake, et al.. (1988). Clinical Evaluation of Intravenous Labetalol for the Treatment of Hypertensive Urgency. American Journal of Hypertension. 1(3 Pt 3). 284S–289S. 16 indexed citations
6.
Askenazi, Joseph, Paul E. MacCosbe, Julie Hoff, et al.. (1987). Hemodynamic Effects of Esmolol, an Ultrashort‐acting Beta Blocker. The Journal of Clinical Pharmacology. 27(8). 567–573. 20 indexed citations
7.
Sung, Ruey J., et al.. (1986). Clinical Experience With Esmolol, A Short‐Acting Beta‐Adrenergic Blocker In Cardiac Arrhythmias and Myocardial Ischemia. The Journal of Clinical Pharmacology. 26(S1). A15–A26. 31 indexed citations
8.
MacCosbe, Paul E. & Alvin B. Segelman. (1984). Effect of an Undergraduate Special Problems Elective Upon Student Knowledge of Antibiotic Therapy. American Journal of Pharmaceutical Education. 48(3). 272–275.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026